Neuroprotective effects of Prosopis cineraria L. ameliorate Alzheimer's disease manifestations
Fatima Aslam1, Qaiser Jabeen1, Saad Touqeer2
1Department of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, 63100, Pakistan.
Ethnopharmacological Relevance:
Prosopis cineraria is traditionally used to enhance cognitive function and manage mental disorders. Its stem bark is valued in ethnomedicine, but its potential anti-Alzheimer's disease (AD) effects are scientifically unexplored.
Aim Of The Study:
This research has examined the neuroprotective effects of the ethyl acetate fraction of P. cineraria bark (Pc-EA) against AlCl3-induced AD pathology, focusing on behavioral, biochemical, histological, and molecular outcomes.
Material And Methods:
Diseased rats were treated with Pc-EA (30, 100, and 300 mg/kg) for 42 days. Cognitive and affective functions were evaluated with behavioral tests on days 29-42. Biochemical assays measured oxidative stress and cholinesterase activity, while RT-PCR quantified neuroinflammatory markers. Histopathological examination was performed to evaluate the integrity of hippocampal regions. Bioactive compounds were identified by phytochemical profiling (HPLC, GC-MS), and molecular docking was performed to assess binding interactions with acetylcholinesterase.
Result:
AlCl3 exposure impaired memory, augmented anxiety and depression-like behavior, elevated oxidative stress, AChE activity, and induced hippocampal neurodegeneration with upregulated BACE-1, Tau, Caspase-3, and NF-κB alongside downregulated BDNF. These changes were reversed by Pc-EA (100 mg/kg), which enhanced cognitive function, restored antioxidant defense, inhibited AChE and neuroinflammatory markers, and maintained hippocampal architecture. Bioactive phytoconstituents (chlorogenic acid, kaempferol, quercetin), which exert anti-amyloidogenic, antioxidant, anti-inflammatory, and acetylcholinesterase inhibitory effects, were identified by HPLC and GC-MS, and their potential roles were corroborated via in silico validation.
Conclusion:
Pc-EA demonstrated multi-targeted neuroprotection in AlCl3-induced AD, which is consistent with ethnomedicinal claims. These findings indicate P. cineraria as a potential modulator of AD through antioxidant, anti-inflammatory, anti-amyloidogenic, and neurotrophic mechanisms.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...


